title: Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells.
abstract: Lung cancers, malignant mesotheliomas (MM), and fibrosis are devastating diseases with limited treatment strategies, in part due to poorly-effective drug delivery to affected areas of lung. We hypothesized that acid-prepared mesoporous spheres (APMS) (1-2 microm diameter, 40 A pore size) might be effective vehicles for pulmonary chemotherapeutic drug delivery. To assess this, APMS, chemically modified with different surface molecules (lipid, a linker having a terminal amine group, a thiol group, or tetraethylene glycol [TEG]), were evaluated for uptake and possible cytotoxic effects after in vitro administration to murine alveolar epithelial Type II (C10) and human mesothelioma (MM) cells and after intrapleural or intranasal administration to C57Bl/6 mice. APMS coated with TEG (APMS-TEG) were most efficiently taken up by C10 and MM cells. The mechanism of cell uptake was rapid, actin-dependent, and did not involve clathrin- or caveolae-mediated mechanisms nor fusion of membrane-bound APMS with lysosomes. When injected intrapleurally in mice, APMS-TEG were taken up by both CD45-positive and -negative cells of the diaphragm, lung, and spleen, whereas APMS administered by the intranasal route were predominantly in lung epithelial cells and alveolar macrophages. After intrapleural or intranasal administration, APMS were nonimmunogenic and nontoxic as evaluated by differential cell counts and lactate dehydrogenase levels in bronchoalveolar and pleural lavage fluids. In the treatment of lung and pleural diseases, APMS-TEG may be useful tools to deliver chemotherapeutic drugs or molecular constructs.
authors.affiliation: Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont 05405, USA.
authors.forename: Steven R
authors.initials: SR
authors.lastname: Blumen
authors.forename: Kai
authors.initials: K
authors.lastname: Cheng
authors.forename: Maria E
authors.initials: ME
authors.lastname: Ramos-Nino
authors.forename: Douglas J
authors.initials: DJ
authors.lastname: Taatjes
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Weiss
authors.forename: Christopher C
authors.initials: CC
authors.lastname: Landry
authors.forename: Brooke T
authors.initials: BT
authors.lastname: Mossman
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid; D002452:Cell Count; D016923:Cell Death; D004847:Epithelial Cells / Q000166:cytology / Q000378:metabolism* / Q000648:ultrastructure; D006801:Humans; D006851:Hydrochloric Acid / Q000378:metabolism*; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008168:Lung / Q000166:cytology*; D008654:Mesothelioma / Q000378:metabolism* / Q000473:pathology / Q000648:ultrastructure; D051379:Mice; D008863:Microspheres; D010957:Plasmids; D010997:Pleural Neoplasms / Q000378:metabolism*; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000378:metabolism; D016062:Porosity; D013997:Time Factors
chemical_list: D011092:Polyethylene Glycols; D007770:L-Lactate Dehydrogenase; D006851:Hydrochloric Acid